Cargando…

A Proposal to Modify the 8th IASLC System: Is it Suitable for T4N2M0 Lung Adenocarcinoma to Be Placed in Stage IIIB?

The International Association for the Study of Lung Cancer (IASLC) of TNM staging system has been well accepted as a precise model. However, the latest American Joint Committee on Cancer (AJCC) staging system to solve the different survival and prognosis of lung adenocarcinoma in the same period is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruan, Tian, Jiang, PengFei, Li, Changsheng, Pan, Gaofeng, Zhou, Xuefeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Articles: Thoracic
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028306/ https://www.ncbi.nlm.nih.gov/pubmed/35446280 http://dx.doi.org/10.1097/COC.0000000000000907

Ejemplares similares

Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma
por: Zabeck, Heike, et al.
Publicado: (2018)

From the IASLC Tobacco Control Committee
Publicado: (2020)

From the IASLC Tobacco Control Committee
Publicado: (2020)

From the IASLC Tobacco Control Committee
Publicado: (2020)

From the IASLC Tobacco Control Committee
Publicado: (2020)

A Simplified Version of the IASLC Grading System for Invasive Pulmonary Adenocarcinomas With Improved Prognosis Discrimination
por: Bossé, Yohan, et al.
Publicado: (2023)

IASLC Textbook of Prevention and Early Detection of Lung Cancer
por: Spiro, S G
Publicado: (2006)

Proposal of a Nomogram for Predicting Survival in Patients with Siewert Type II Adenocarcinoma of the Esophagogastric Junction After Preoperative Radiation
por: Liu, Feng, et al.
Publicado: (2019)

Comment on “EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach”
por: Vigneswaran, Wickii T., et al.
Publicado: (2020)

The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapy
por: E, Haoran, et al.
Publicado: (2023)

A pretreatment prediction model of grade 3 tumors classed by the IASLC grading system in lung adenocarcinoma
por: Wang, Kai, et al.
Publicado: (2023)

Radiological and clinical features of screening-detected pulmonary invasive mucinous adenocarcinoma
por: Kim, Dae Hyeon, et al.
Publicado: (2021)

Sublobar resection versus lobectomy for patients with stage T1-2N0M0 pulmonary typical carcinoid tumours: a population-based propensity score matching analysis
por: Yang, Hao, et al.
Publicado: (2022)

Pathological and clinical features of multiple cancers and lung adenocarcinoma: a multicentre study
por: Bertoglio, Pietro, et al.
Publicado: (2022)

A radiomics model can distinguish solitary pulmonary capillary haemangioma from lung adenocarcinoma
por: Wang, Hao-Jen, et al.
Publicado: (2021)

Preoperative monocyte count is a predictor of recurrence after Stage I lung adenocarcinoma resection
por: Yoshida, Chihiro, et al.
Publicado: (2022)

Place of robotic surgery in completion lobectomy after anatomical segmentectomy
por: Piccoli, Juliette, et al.
Publicado: (2023)

Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma
por: Wang, Hongyan, et al.
Publicado: (2018)

Combination of epidermal growth factor receptor mutation and the presence of high-grade patterns is associated with recurrence in resected stage I lung adenocarcinoma
por: Kondo, Yasuto, et al.
Publicado: (2022)

Modified Nuss procedure with a novel steel bar in patients with pectus excavatum post-congenital heart surgery
por: Liu, Siming, et al.
Publicado: (2021)

Validation of the Proposed cN2 Subclassification in the Eighth Edition of the IASLC Staging System: A Prospective Phase II Multicenter Study
por: Abe, Jiro, et al.
Publicado: (2020)

Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea
por: Woo, Wongi, et al.
Publicado: (2022)

Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification
por: Shimada, Yoshihisa, et al.
Publicado: (2013)

New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma
por: Weng, Ching-Fu, et al.
Publicado: (2020)

Correlation of Epidermal Growth Factor Receptor Mutation With Major Histologic Subtype of Lung Adenocarcinoma According to IASLC/ATS/ERS Classification
por: Boukansa, Sara, et al.
Publicado: (2022)

Descending necrotizing mediastinitis and the proposal of a new classification
por: Sugio, Kenji, et al.
Publicado: (2021)

A nomogram to predict residual cavity formation after thoracoscopic decortication in chronic tuberculous empyema
por: Zhu, Pengfei, et al.
Publicado: (2022)

Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma
por: Sun, Yifeng, et al.
Publicado: (2016)

A predictive nomogram for lymph node metastasis in part-solid invasive lung adenocarcinoma: A complement to the IASLC novel grading system
por: Gao, Zhaoming, et al.
Publicado: (2022)

Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer
por: Talsma, Koen, et al.
Publicado: (2012)

Supplementary Prognostic Variables for Pleural Mesothelioma: A Report from the IASLC Staging Committee
por: Pass, Harvey I., et al.
Publicado: (2014)

Associations between epidermal growth factor receptor mutations and histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification in Chinese patients
por: Wang, Tengteng, et al.
Publicado: (2017)

Having a Suitable Reference Place
por: Vahabi, Fataneh, et al.
Publicado: (2013)

High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma
por: Jomrich, Gerd, et al.
Publicado: (2019)

Volume and Mass Doubling Time of Lung Adenocarcinoma according to WHO Histologic Classification
por: Hong, Jung Hee, et al.
Publicado: (2021)

Risk of Thromboembolic Events after Perioperative Chemotherapy Versus Surgery Alone for Esophageal Adenocarcinoma
por: Verhage, Roy J. J., et al.
Publicado: (2011)

The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma
por: van Hootegem, Sander J. M., et al.
Publicado: (2019)

The Value of Paratracheal Lymphadenectomy in Esophagectomy for Adenocarcinoma of the Esophagus or Gastroesophageal Junction: A Systematic Review of the Literature
por: Gantxegi, Amaia, et al.
Publicado: (2021)

Clinicopathological and prognostic significance of metastasis-associated protein 1 expression and its correlation with angiogenesis in lung invasive adenocarcinomas, based on the 2011 IASLC/ATS/ERS classification
por: LI, SHUHAI, et al.
Publicado: (2016)

Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification
por: Zhao, Shilei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jrtfl4c5d6g9vgtopddjdpeanh